What's new? Log in Free sign up

Outset Medical (OM)

Company Profile

Company profile

Ticker

OM

Exchange

Website

www.outsetmedical.com

CEO

Ms. Leslie L. Trigg

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

Varian Medical Systems • CONMED • Integer • Runway Growth Finance • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • FONAR ...

Former names

[object Object]

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

200514392

OM stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Quarterly report

6 Nov 24

Outset Medical Reports Third Quarter 2024 Financial Results

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

Departure of Directors or Certain Officers

Submission of Matters to a Vote of Security Holders

Conflict minerals disclosure

Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance

Additional proxy soliciting materials

Definitive proxy

11 Apr 24

Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

John L. Brottem

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

VANGUARD GROUP INC

MILLENNIUM MANAGEMENT LLC

Financial summary

Financial statements Chart OM financial data

Quarter (USD)	Sep 24	Dec 23	Sep 23	Jun 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

OM institutional ownership history Ownership history

96.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	120	97	+23.7%
Opened positions	46	24	+91.7%
Closed positions	23	36	-36.1%
Increased positions	26	23	+13.0%
Reduced positions	30	32	-6.3%

13F shares	Current	Prev Q	Change
Total value	176.50 bn	88.08 bn	+100.4%
Total shares	48.57 mm	42.84 mm	+13.4%
Total puts	91.30 k	15.20 k	+500.7%
Total calls	65.10 k	0.00	NEW
Total put/call ratio	1.4	Infinity	NaN%

Largest owners	Shares	Value	Change
FMR	7.70 mm	$29.63 bn	+10.8%
AMP Ameriprise Financial	5.20 mm	$20.02 bn	+1.7%
MS Morgan Stanley	3.82 mm	$14.69 bn	-4.9%
JPM JPMorgan Chase & Co.	3.07 mm	$11.83 bn	-1.3%
Vanguard	2.65 mm	$10.19 bn	-8.5%
Millennium Management	1.94 mm	$7.48 bn	NEW
Massachusetts Financial Services	1.54 mm	$5.92 bn	+118.5%
Assenagon Asset Management	1.52 mm	$5.83 bn	+60.4%
GMT Capital	1.47 mm	$5.67 bn	NEW
Mubadala Investment Co PJSC	1.44 mm	$5.55 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	880.46 k	-2.39 mm	-73.0%
Millennium Management	1.94 mm	+1.94 mm	NEW
GMT Capital	1.47 mm	+1.47 mm	NEW
D. E. Shaw & Co.	1.28 mm	+1.28 mm	NEW
Massachusetts Financial Services	1.54 mm	+834.66 k	+118.5%
STT State Street	210.17 k	-799.30 k	-79.2%
FMR	7.70 mm	+749.05 k	+10.8%
Braidwell	694.53 k	+694.53 k	NEW
Jane Street	891.81 k	+665.97 k	+294.9%
Assenagon Asset Management	1.52 mm	+570.28 k	+60.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

OM insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Nov 24	Nabeel Ahmed	Common Stock	Sell	Dispose S	No	No	0.8	4,221	3.38 k	310,767
15 Nov 24	John L. Brottem	Common Stock	Sell	Dispose S	No	No	0.8	3,203	2.56 k	227,092
15 Nov 24	Marc Nash	Common Stock	Sell	Dispose S	No	No	0.8	1,375	1.10 k	238,022
15 Nov 24	Leslie Trigg	Common Stock	Sell	Dispose S	No	No	0.8	5,645	4.52 k	904,851
15 Aug 24	John L. Brottem	Common Stock	Sell	Dispose S	No	No	0.84	3,011	2.53 k	230,295

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Ondo Finance, Ethereum's BlackRock-Backed Tokenization Crypto, Surges 38%: Why Is ONDO Going Up?

Ondo Finance (CRYPTO: ONDO), a tokenization-themed cryptocurrency with ties to BlackRock, has surged over 35% in the last 24 hours.

Outset Medical Q3 2024 Adj. EPS $(0.39) Beats $(0.42) Estimate, Sales $28.666M Beat $26.905M Estimate

Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.42) by 7.14 percent. The company reported quarterly sales of $28.666 million which beat the

Outset Medical Raises FY2024 Sales Guidance from $110.00M to $112.00M

Outset Medical (NASDAQ:OM) raises FY2024 sales outlook from $110.00 million to $112.00 million.

Bitcoin, Ethereum, Dogecoin Dip After Strong Tuesday—Analysts Predict 'Unprecedented Highs Can Be In Development'

Crypto Trader Details 'Plan To Make Millions: 2-3 Top Picks Per Sector Rather Than Dispersing Investments'

Press releases

From Benzinga Pro

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ:OM) on behalf of

Outset Medical to Present at the 2024 Stifel Healthcare Conference

SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,

DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - OM

OM DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages Outset Medical, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.